CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to GILD

Therapeutic Hydrocortisone

Phase 2
Gilead Sciences, Inc. (GILD)

Phase 2

Development Phase

0

Upcoming Catalysts

0

Historical Events

3

Regulatory Approvals

No Catalysts Found

No catalyst events have been recorded for this drug yet.

Competitive Landscape

1 competitor in Non-hodgkin Lymphoma

View Full Landscape
Drug Information

Target Indication

Non-hodgkin Lymphoma

Clinical Trial

NCT07763210

Last updated: 10/23/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Regulatory Approvals
EMAPending

Hydrocortisone Aguettant

View on EMA
EMA5/27/2021

Efmody

Treatment of congenital adrenal hyperplasia (CAH) in adolescents aged 12 years and over and adults.

View on EMA
EMA2/9/2018

Alkindi

Replacement therapy of adrenal insufficiency in infants, children and adolescents (from birth to < 18 years old).

View on EMA
Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.